Cargando…
Individualized immunosuppression in transplant patients: potential role of pharmacogenetics
The immunosuppressive drugs used to prevent the rejection of transplanted organs have a narrow therapeutic index. Under treatment results in episodes of rejection leading to either damage or loss of the organ. Over immunosuppression increases the risk of infection and malignancy as well as drug spec...
Autores principales: | Abboudi, Hamid, MacPhee, Iain AM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513229/ https://www.ncbi.nlm.nih.gov/pubmed/23226063 http://dx.doi.org/10.2147/PGPM.S21743 |
Ejemplares similares
-
Patient involvement in selection of immunosuppressive regimen following transplantation
por: Popoola, Joyce, et al.
Publicado: (2014) -
Use of Pharmacogenetics to Optimize Immunosuppressant Therapy in Kidney-Transplanted Patients
por: Urzì Brancati, Valentina, et al.
Publicado: (2022) -
Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
por: Phanish, Mysore K., et al.
Publicado: (2020) -
Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapy
por: Salvadori, Maurizio, et al.
Publicado: (2020) -
Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
por: El‐Nahhas, Toqa, et al.
Publicado: (2021)